Long term survival of childhood cancers is now more than 70%. Anthracyclines, including doxorubicin, are some of the most efficacious anticancer drugs available. However, its use as a chemotherapeutic agent is severely hindered by its dose-limiting toxicities. Most notably observed is cardiotoxicity, but other organ systems are also degraded by doxorubicin use. Despite the years…
IJC Heart & Vasculature Template
Write in a clean editor, then format for IJC Heart & Vasculature in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the IJC Heart & Vasculature format
IJC Heart & Vasculature is a peer-reviewed journal published by Elsevier, covering Atrial Fibrillation Management and Outcomes, Cardiovascular Function and Risk Factors, Cardiac Imaging and Diagnostics.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, IJC Heart & Vasculature 12 (2023) 45–58.
Formats any DOI in IJC Heart & Vasculature style. No sign-up. |
| Publishes research in | Atrial Fibrillation Management and Outcomes Cardiovascular Function and Risk Factors Cardiac Imaging and Diagnostics Cardiac Valve Diseases and Treatments Acute Myocardial Infarction Research |
| ISSN | 2352-9067 |
| Citation impact (2-yr) | 1.8 |
| h-index | 47 |
| i10-index | 518 |
| Total citations | 16,983 |
| Article processing charge | $2,696 |
| Open access | Yes |
| Top institutions publishing here | West German Heart and Vascular Center Essen |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in IJC Heart & Vasculature per year
Citation impact of IJC Heart & Vasculature by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in IJC Heart & Vasculature
Pulmonary hypertension is a pathological haemodynamic condition defined as an increase in mean pulmonary arterial pressure ≥ 25 mmHg at rest, assessed using gold standard investigation by right heart catheterisation. Pulmonary hypertension could be a complication of cardiac or pulmonary disease, or a primary disorder of small pulmonary arteries. Elevated pulmonary pressure (PAP) is associated…
Coronavirus disease 2019 (COVID-19) is a novel, highly transmittable and severe strain disease, which has rapidly spread worldwide. Despite epidemiological evidence linking COVID-19 with cardiovascular diseases, little is known about whether and how COVID-19 influences atrial fibrillation (AF), the most prevalent arrhythmia in clinical practice. Here, we review the available evidence for prevalence and incidence…
BACKGROUND: A significant proportion of patients develop heart failure (HF) after acute myocardial infarction (MI). Predicting this development with novel biomarkers would allow tailoring healthcare to each individual. We recently identified a circular RNA called MICRA which was associated with HF development after MI. Here, we tested whether MICRA was able to risk stratify MI…
Diseases affecting the brain contribute to a substantial proportion of morbidity and mortality in the general population. Conditions such as stroke, dementia and cognitive impairment have a prominent impact on global public health. Despite the heterogeneous clinical manifestations of these conditions and their diverse prognostic implications, current evidence supports a role for cardiovascular disease as…